| | | | | | | | While the advantages of embracing Pharma 4.0 and climbing the digitalization hierarchy are clear, scaling the ladder is easier said than done for some pharma companies. The journey from the digital silos and connected plant phases to a predictive plant may seem long and tedious, but with the correct data, instrumentation and technology, companies can take a stand against obsolescence and reach their digital maturation goals. |
|
|
|
| |
| | |
|
|
| | | | | The partners will develop in vivo CRISPR-based gene editing therapies in a deal that could reach $470 million. |
|
|
| The "strategic productivity initiative" — which will result in ~2,200 layoffs — is designed to drive $1.5 billion in cost savings by the end of 2025. |
|
|
|
| |
| | |
|
|
| | | | Sponsored | | mRNA-LNP manufacturing is fraught with obstacles, resulting in higher program risk, inflated costs, and delayed market release. With the right knowledge, companies can overcome the challenges to de-risk & optimize the path to manufacturing success. |
|
|
|
| |
| | |
|
|
| | |
|
| | |
|
